» Articles » PMID: 32230710

Urinary Arsenic Species Are Detectable in Urban Underserved Hispanic/Latino Populations: A Pilot Study from the Study of Latinos: Nutrition & Physical Activity Assessment Study (SOLNAS)

Abstract

Background: Hispanics/Latinos represent >15% of the United States (US) population and experience a high burden of cardiovascular disease (CVD) and diabetes. Dietary exposure, particularly to arsenic (As), may be associated with CVD and diabetes in Hispanics/Latinos. Rural populations in the US exposed to As in drinking water have increased risk of diabetes and CVD; however, little is known about the risk among urban populations with low As in water who are mostly exposed to As through food.

Methods: To explore the levels of inorganic arsenic exposure (the sum of inorganic and methylated arsenic species in urine, ∑As, corrected by a residual-based method) in persons of Hispanic/Latino origin, we conducted a pilot study quantifying urinary arsenic levels among 45 participants in the Study of Latinos: Nutrition & Physical Activity Assessment Study (SOLNAS).

Results: The median (interquartile range) of the urinary arsenic species (µg/L) were as follows: inorganic As 0.6 (0.4, 1.0), monomethylarsonic acid 1.2 (0.7, 1.9), dimethylarsinic acid 7.2 (4.3, 15.3), and ∑As 6.0 (4.3, 10.5).

Conclusions: This study adds to the existing evidence that harmful forms of arsenic are present in this group of Hispanics/Latinos.

Citing Articles

Arsenic Exposure, Arsenic Metabolism, and Glycemia: Results from a Clinical Population in New York City.

Wu F, Chen Y, Navas-Acien A, Garabedian M, Coates J, Newman J Int J Environ Res Public Health. 2021; 18(7).

PMID: 33916749 PMC: 8038318. DOI: 10.3390/ijerph18073749.

References
1.
Micha R, Penalvo J, Cudhea F, Imamura F, Rehm C, Mozaffarian D . Association Between Dietary Factors and Mortality From Heart Disease, Stroke, and Type 2 Diabetes in the United States. JAMA. 2017; 317(9):912-924. PMC: 5852674. DOI: 10.1001/jama.2017.0947. View

2.
Kuo C, Moon K, Wang S, Silbergeld E, Navas-Acien A . The Association of Arsenic Metabolism with Cancer, Cardiovascular Disease, and Diabetes: A Systematic Review of the Epidemiological Evidence. Environ Health Perspect. 2017; 125(8):087001. PMC: 5880251. DOI: 10.1289/EHP577. View

3.
LaVange L, Kalsbeek W, Sorlie P, Aviles-Santa L, Kaplan R, Barnhart J . Sample design and cohort selection in the Hispanic Community Health Study/Study of Latinos. Ann Epidemiol. 2010; 20(8):642-9. PMC: 2921622. DOI: 10.1016/j.annepidem.2010.05.006. View

4.
Geiss L, Wang J, Cheng Y, Thompson T, Barker L, Li Y . Prevalence and incidence trends for diagnosed diabetes among adults aged 20 to 79 years, United States, 1980-2012. JAMA. 2014; 312(12):1218-26. DOI: 10.1001/jama.2014.11494. View

5.
Sams 2nd R, Wolf D, Ramasamy S, Ohanian E, Chen J, Lowit A . Workshop overview: arsenic research and risk assessment. Toxicol Appl Pharmacol. 2007; 222(3):245-51. DOI: 10.1016/j.taap.2007.01.007. View